Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

IF 3.1 3区医学 Q2 PHARMACOLOGY & PHARMACY

CPT: Pharmacometrics & Systems Pharmacology Pub Date : 2025-04-03 DOI:10.1002/psp4.70028

André Dallmann, Denise Feick, Pavel Balazki, Salih Benamara, Rolf Burghaus, Marylore Chenel, Siak-Leng Choi, Henrik Cordes, Mariana Guimarães, Abdullah Hamadeh, Ibrahim Ince, Kathleen M Job, Tobias Kanacher, Andreas Kovar, Lars Kuepfer, Jörg Lippert, Julia Macente, Nina Nauwelaerts, Christoph Niederalt, Sheila Peters, Susana Proença, Masanobu Sato, Stephan Schaller, Jan Frederik Schlender, Annika Schneider, Erik Sjögren, Juri Solodenko, Alexander Staab, Paul Vrenken, Thomas Wendl, Wilhelmus E A de Witte, Donato Teutonico

引用次数: 0

Abstract

In 2017, the free and open-source software Open Systems Pharmacology (OSP) was launched. Since then, OSP has evolved from a small community into a diverse network of stakeholders committed to advancing open-source solutions for model-informed drug development (MIDD). In this context, the first OSP Community Conference was hosted by Novartis in Basel, Switzerland, on October 7-8, 2024, which gathered over 100 attendees from more than 40 institutions. This perspective synthesizes key insights from the conference.

查看原文本刊更多论文

利用开源解决方案：来自第一届开放系统药理学（OSP）社区会议的见解。

2017年，免费开源软件开放系统药理学（OSP）推出。从那时起，OSP已经从一个小型社区发展成为一个多元化的利益相关者网络，致力于推进基于模型的药物开发（MIDD）的开源解决方案。在此背景下，诺华公司于2024年10月7日至8日在瑞士巴塞尔举办了第一届OSP社区会议，来自40多个机构的100多名与会者参加了会议。这一观点综合了会议的重要见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊